Bodkin JA, Zornberg GL, Lukas SE, Cole JO (February 1995). "Buprenorphine treatment of refractory depression". Journal of Clinical Psychopharmacology. 15 (1): 49–57. doi:10.1097/00004714-199502000-00008. PMID7714228.
Wing DA, Powers B, Hickok D (April 2010). "U.S. Food and Drug Administration drug approval: slow advances in obstetric care in the United States". Obstetrics and Gynecology. 115 (4): 825–833. doi:10.1097/AOG.0b013e3181d53843. PMID20308845.
Wells RE, Turner DP, Lee M, Bishop L, Strauss L (April 2016). "Managing Migraine During Pregnancy and Lactation". Current Neurology and Neuroscience Reports. 16 (4): 40. doi:10.1007/s11910-016-0634-9. PMID27002079. S2CID10098257.
Gracer R (February 2007). "The Buprenorphine Effect on Depression"(PDF). naabt.org. National Alliance of Advocates for Buprenorphine Treatment. Retrieved 19 September 2015.
Bodkin JA, Zornberg GL, Lukas SE, Cole JO (February 1995). "Buprenorphine treatment of refractory depression". Journal of Clinical Psychopharmacology. 15 (1): 49–57. doi:10.1097/00004714-199502000-00008. PMID7714228.
Wing DA, Powers B, Hickok D (April 2010). "U.S. Food and Drug Administration drug approval: slow advances in obstetric care in the United States". Obstetrics and Gynecology. 115 (4): 825–833. doi:10.1097/AOG.0b013e3181d53843. PMID20308845.
Wells RE, Turner DP, Lee M, Bishop L, Strauss L (April 2016). "Managing Migraine During Pregnancy and Lactation". Current Neurology and Neuroscience Reports. 16 (4): 40. doi:10.1007/s11910-016-0634-9. PMID27002079. S2CID10098257.
Wells RE, Turner DP, Lee M, Bishop L, Strauss L (April 2016). "Managing Migraine During Pregnancy and Lactation". Current Neurology and Neuroscience Reports. 16 (4): 40. doi:10.1007/s11910-016-0634-9. PMID27002079. S2CID10098257.